A new beginning: can omidubicel emerge as the next, viable alternative donor source?

Umbilical cord blood (UCB) transplantation (CBT) has been an important alternative donor option for patients lacking matched related donor (MRD) or unrelated donor (URD) grafts. Only 30% of patients with high-risk hematologic malignancies have a human leukocyte antigen (HLA)-identical sibling; subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Arpita P., Newell, Laura F., Maziarz, Richard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469227/
https://www.ncbi.nlm.nih.gov/pubmed/37664800
http://dx.doi.org/10.1177/20406207231192146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469227/
https://www.ncbi.nlm.nih.gov/pubmed/37664800
http://dx.doi.org/10.1177/20406207231192146

Ejemplares similares